The Joplin Globe, Joplin, MO

Business

July 30, 2013

Pfizer to pay $491M to resolve drug marketing case

NEW YORK — Pfizer and the Justice Department say the drugmaker will pay almost $491 million to resolve an investigation into illegal marketing of the company’s organ transplant drug Rapamune.

Rapamune was approved in 1999 for use in kidney transplant patients, and the Justice Department says sales representatives were trained to market the drug for use in other patients.

The U.S. Department of Justice says Pfizer Inc. will pay $257.4 million in civil settlements with federal and state governments and a $157.6 million criminal fine. It will also forfeit $76 million in assets.

Rapamune was originally made by Wyeth. Pfizer bought Wyeth in 2009.

The parties announced a proposed $491 million settlement in October.

 

1
Text Only
Business
Poll

Do you plan on voting in the Aug. 5 elections being held in Missouri and Kansas?

Yes
No
     View Results
Facebook
Twitter Updates
Follow us on twitter
NDN Video
Renewed Violence Taking Toll on Gaza Residents 2 Americans Detained in North Korea Seek Help US Employers Add 209K Jobs, Rate 6.2 Pct House GOP Optimistic About New Border Bill Gaza Truce Unravels; Israel, Hamas Trade Blame Raw: Tunisia Closes Borders With Libya Four Rescued From Crashed Plane Couple Channel Grief Into Soldiers' Retreat WWI Aviation Still Alive at Aerodrome in NY Raw: Rescuers at Taiwan Explosion Scene Raw: Woman Who Faced Death Over Faith in N.H. Clinton Before 9-11: Could Have Killed Bin Laden Netanyahu Vows to Destroy Hamas Tunnels Obama Slams Republicans Over Lawsuit House Leaders Trade Blame for Inaction